Our lab has previously demonstrated that F508del homozygous CF mice demonstrate enhanced TGFβ-induced AHR, bronchodilator response, and goblet cell hyperplasia when compared to littermate controls [18]. The gene discussed is TGFB1; the disease is cystic fibrosis.